HealthSun Pharma to Present Long-Term UNLOXCYT Data at ESMO After 205-Patient Study UpdateBy Naomi CalderOct 23, 2026, 11:15 PM UTC
HealthSkin Cancer Guidelines Add UNLOXCYT as Category 2A Option, Sun Pharma SaysBy Naomi CalderOct 21, 2026, 1:20 AM UTC